HIGHLIGHTS
- who: Angela L. Bosma MD from the Amsterdam and Rotterdam, the NetherlandsAmsterdam University have published the research work: Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry, in the Journal: (JOURNAL) of May/28,/2020
- what: Long-term dupilumab treatment in a routine clinical setting can be considered an effective treatment in patients with AD in combination with topical treatment and initial systemic therapy, showing a sustained improvement of investigator-reported and patient-reported outcomes up to 84 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.